Catheter Precision, Inc. (NYSEAMERICAN:VTAK) Short Interest Up 54.0% in February

Catheter Precision, Inc. (NYSEAMERICAN:VTAK) saw a large increase in short interest in February. As of February 15th, there was short interest totalling 126,400 shares, an increase of 54.0% from the January 31st total of 82,100 shares. Based on an average daily volume of 328,300 shares, the short-interest ratio is presently 0.4 days. Approximately 1.7% of the company’s shares are sold short.

Catheter Precision Price Performance

Shares of VTAK traded up $0.02 during trading hours on Tuesday, hitting $0.33. The stock had a trading volume of 74,926 shares, compared to its average volume of 399,510. Catheter Precision has a 1-year low of $0.31 and a 1-year high of $8.40. The company has a debt-to-equity ratio of 0.12, a quick ratio of 0.65 and a current ratio of 0.66.

Institutional Investors Weigh In On Catheter Precision

A hedge fund recently raised its stake in Catheter Precision stock. Warberg Asset Management LLC lifted its holdings in shares of Catheter Precision, Inc. (NYSEAMERICAN:VTAK) by 362.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 310,164 shares of the company’s stock after acquiring an additional 243,164 shares during the period. Warberg Asset Management LLC owned approximately 3.51% of Catheter Precision worth $140,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 20.34% of the company’s stock.

Catheter Precision Company Profile

Catheter Precision, Inc designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company’s lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures.